Published in Infect Immun on December 01, 1993
Exotoxins of Staphylococcus aureus. Clin Microbiol Rev (2000) 7.35
Imaging alpha-hemolysin with molecular dynamics: ionic conductance, osmotic permeability, and the electrostatic potential map. Biophys J (2005) 4.45
Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis (2010) 4.19
Novel path to apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradation. Infect Immun (1994) 2.47
A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J Immunol (2009) 2.29
Potassium-inhibited processing of IL-1 beta in human monocytes. EMBO J (1995) 2.08
A pore-forming toxin interacts with a GPI-anchored protein and causes vacuolation of the endoplasmic reticulum. J Cell Biol (1998) 2.04
Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front Cell Infect Microbiol (2012) 1.84
Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection. Cell Microbiol (2007) 1.72
Subcytocidal attack by staphylococcal alpha-toxin activates NF-kappaB and induces interleukin-8 production. Infect Immun (2001) 1.71
Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother (1998) 1.70
Staphylococcus aureus activation of caspase 1/calpain signaling mediates invasion through human keratinocytes. J Infect Dis (2012) 1.66
RNAs: regulators of bacterial virulence. Nat Rev Microbiol (2010) 1.63
alpha-Hemolysin, gamma-hemolysin, and leukocidin from Staphylococcus aureus: distant in sequence but similar in structure. Protein Sci (1997) 1.62
Analysis of expression of the alpha-toxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla::lacZ gene fusion. Infect Immun (1997) 1.61
Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci U S A (1997) 1.58
Polymeric nonelectrolytes to probe pore geometry: application to the alpha-toxin transmembrane channel. Biophys J (1999) 1.53
RAB-5- and RAB-11-dependent vesicle-trafficking pathways are required for plasma membrane repair after attack by bacterial pore-forming toxin. Cell Host Microbe (2011) 1.35
Intracellular Staphylococcus aureus: live-in and let die. Front Cell Infect Microbiol (2012) 1.33
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. J Clin Invest (2005) 1.30
Phenol-soluble modulins--critical determinants of staphylococcal virulence. FEMS Microbiol Rev (2014) 1.21
Cytotoxic action of Serratia marcescens hemolysin on human epithelial cells. Infect Immun (1999) 1.21
SarA is a repressor of hla (alpha-hemolysin) transcription in Staphylococcus aureus: its apparent role as an activator of hla in the prototype strain NCTC 8325 depends on reduced expression of sarS. J Bacteriol (2006) 1.16
Potent membrane-permeabilizing and cytocidal action of Vibrio cholerae cytolysin on human intestinal cells. Infect Immun (1997) 1.15
Regulation of human airway ciliary beat frequency by intracellular pH. J Physiol (2004) 1.04
Caspase-2 is an initiator caspase responsible for pore-forming toxin-mediated apoptosis. EMBO J (2012) 1.01
The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections. Expert Opin Ther Targets (2012) 0.98
Staphylococcus aureus α-toxin-dependent induction of host cell death by membrane-derived vesicles. PLoS One (2013) 0.98
Pro-autophagic signal induction by bacterial pore-forming toxins. Med Microbiol Immunol (2010) 0.98
Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infection. Prog Retin Eye Res (2012) 0.96
Systemic dissemination and cutaneous damage in a mouse model of staphylococcal skin infections. Microb Pathog (2009) 0.96
Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity. Curr Immunol Rev (2006) 0.96
Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin. Infect Immun (2007) 0.95
Binding, oligomerization, and pore formation by streptolysin O in erythrocytes and fibroblast membranes: detection of nonlytic polymers. Infect Immun (1995) 0.93
Haemolysis induced by α-toxin from Staphylococcus aureus requires P2X receptor activation. Pflugers Arch (2011) 0.89
Staphylococcal alpha-toxin is not sufficient to mediate escape from phagolysosomes in upper-airway epithelial cells. Infect Immun (2009) 0.88
Membrane Repair: Mechanisms and Pathophysiology. Physiol Rev (2015) 0.88
The adherens junctions control susceptibility to Staphylococcus aureus α-toxin. Proc Natl Acad Sci U S A (2015) 0.84
Interferons increase cell resistance to Staphylococcal alpha-toxin. Infect Immun (2007) 0.84
An important role of α-hemolysin in extracellular vesicles on the development of atopic dermatitis induced by Staphylococcus aureus. PLoS One (2014) 0.83
Staphylococcus aureus alpha-toxin mediates general and cell type-specific changes in metabolite concentrations of immortalized human airway epithelial cells. PLoS One (2014) 0.83
Different types of cell death induced by enterotoxins. Toxins (Basel) (2010) 0.82
The Role of Staphylococcus aureus Virulence Factors in Skin Infection and Their Potential as Vaccine Antigens. Pathogens (2016) 0.79
Diverse modulation of spa transcription by cell wall active antibiotics in Staphylococcus aureus. BMC Res Notes (2012) 0.79
Staphylococcus aureus biofilms decrease osteoblast viability, inhibits osteogenic differentiation, and increases bone resorption in vitro. BMC Musculoskelet Disord (2013) 0.79
A multi-omics approach identifies key hubs associated with cell type-specific responses of airway epithelial cells to staphylococcal alpha-toxin. PLoS One (2015) 0.79
A critical role for hemolysin in Vibrio fluvialis-induced IL-1β secretion mediated by the NLRP3 inflammasome in macrophages. Front Microbiol (2015) 0.78
Effect of enterohaemorrhagic Escherichia coli O157:H7-specific enterohaemolysin on interleukin-1β production differs between human and mouse macrophages due to the different sensitivity of NLRP3 activation. Immunology (2015) 0.78
Suppression of cell membrane permeability by suramin: involvement of its inhibitory actions on connexin 43 hemichannels. Br J Pharmacol (2014) 0.78
Low density lipoprotein inactivates Vibrio vulnificus cytolysin through the oligomerization of toxin monomer. Med Microbiol Immunol (2004) 0.77
The Janus face of α-toxin: a potent mediator of cytoprotection in staphylococci-infected macrophages. J Innate Immun (2014) 0.76
Checks and balances: the ocular response to infection. Virulence (2010) 0.75
Novel Staphylococcus aureus Secreted Protein Alters Keratinocyte Proliferation and Elicits a Proinflammatory Response In Vitro and In Vivo. Biochemistry (2015) 0.75
Possible reason for preferential damage to renal tubular epithelial cells evoked by amphotericin B. Antimicrob Agents Chemother (1996) 0.75
Beyond Hygiene: Commensal Microbiota and Allergic Diseases. Immune Netw (2017) 0.75
ATP Release from Human Airway Epithelial Cells Exposed to Staphylococcus aureus Alpha-Toxin. Toxins (Basel) (2016) 0.75
Alpha-toxin of Staphylococcus aureus. Microbiol Rev (1991) 6.14
On the mechanism of membrane damage by Staphylococcus aureus alpha-toxin. J Cell Biol (1981) 4.06
Nonenteric toxins of Staphylococcus aureus. Microbiol Rev (1979) 2.95
Ionic channels formed by Staphylococcus aureus alpha-toxin: voltage-dependent inhibition by divalent and trivalent cations. J Membr Biol (1986) 2.82
Primary sequence of the alpha-toxin gene from Staphylococcus aureus wood 46. Infect Immun (1984) 2.60
Isolation and identification of two hemolytic forms of streptolysin-O. Infect Immun (1984) 2.57
Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infect Immun (1989) 2.42
A guide to the use of pore-forming toxins for controlled permeabilization of cell membranes. Med Microbiol Immunol (1993) 2.37
Damage to cell membranes by pore-forming bacterial cytolysins. Prog Allergy (1988) 2.23
Toxins of Staphylococcus aureus. Pharmacol Ther (1982) 2.08
Correlation between toxin binding and hemolytic activity in membrane damage by staphylococcal alpha-toxin. Infect Immun (1984) 2.01
Assembly of the oligomeric membrane pore formed by Staphylococcal alpha-hemolysin examined by truncation mutagenesis. J Biol Chem (1992) 1.93
Secondary structure and assembly mechanism of an oligomeric channel protein. Biochemistry (1985) 1.90
Staphylococcal alpha toxin promotes blood coagulation via attack on human platelets. J Exp Med (1988) 1.79
Studies on the binding of staphylococcal 125I-labeled alpha-toxin to rabbit erythrocytes. Biochemistry (1976) 1.76
Functional expression of the alpha-hemolysin of Staphylococcus aureus in intact Escherichia coli and in cell lysates. Deletion of five C-terminal amino acids selectively impairs hemolytic activity. J Biol Chem (1992) 1.76
Membrane damage by hemolytic viruses, toxins, complement, and other cytotoxic agents. A common mechanism blocked by divalent cations. J Biol Chem (1986) 1.68
Bacterial exotoxins and endothelial permeability for water and albumin in vitro. Am J Physiol (1988) 1.61
Staphylococcal alpha-toxin-induced PGI2 production in endothelial cells: role of calcium. Am J Physiol (1985) 1.57
Minimal requirements for exocytosis. A study using PC 12 cells permeabilized with staphylococcal alpha-toxin. J Biol Chem (1985) 1.40
Determination of toxin-induced leakage of different-size nucleotides through the plasma membrane of human diploid fibroblasts. Infect Immun (1975) 1.39
Characterization of hormone and protein release from alpha-toxin-permeabilized chromaffin cells in primary culture. J Biol Chem (1986) 1.38
Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin. Infect Immun (1991) 1.37
Staphylococcus aureus alpha-toxin. Dual mechanism of binding to target cells. J Biol Chem (1991) 1.30
Pore formation by Staphylococcus aureus alpha-toxin in lipid bilayers. Dependence upon temperature and toxin concentration. Eur Biophys J (1987) 1.24
Staphylococcal alpha-toxin: a study of membrane penetration and pore formation. J Biol Chem (1989) 1.20
Staphylococcal alpha-toxin increases the permeability of lipid vesicles by cholesterol- and pH-dependent assembly of oligomeric channels. Eur J Biochem (1989) 1.13
Effect of calcium ions on staphylococcal alpha-toxin-induced hemolysis of rabbit erythrocytes. Infect Immun (1985) 1.06
Growth-related changes of oxygen consumption rates of tumor cells grown in vitro and in vivo. J Cell Physiol (1989) 1.05
Functional complementation of staphylococcal alpha-hemolysin fragments. Overlaps, nicks, and gaps in the glycine-rich loop. J Biol Chem (1993) 1.02
Proliferation-associated oxygen consumption and morphology of tumor cells in monolayer and spheroid culture. J Cell Physiol (1992) 1.00
Interaction of the alpha-toxin of Staphylococcus aureus with the liposome membrane. J Biol Chem (1987) 0.93
Staphylococcus aureus alpha-toxin permeabilizes the basolateral membrane of a Cl(-)-secreting epithelium. Am J Physiol (1992) 0.92
Structural features of the pore formed by Staphylococcus aureus alpha-toxin inferred from chemical modification and primary structure analysis. FEMS Microbiol Immunol (1992) 0.90
A sensitive continuous and discontinuous photometric determination of oxygen, carbon dioxide, and carbon monoxide in gases and fluids. Anal Biochem (1979) 0.89
An automated continuous determination of oxygen with high sensitivity. Anal Biochem (1976) 0.88
A new photometric method for oxygen consumption measurements in cell suspensions. J Appl Physiol (1985) (1986) 0.84
Multiparameter flow cytometric analysis of a novel cytotoxin (factor 2) induced tumor cell membrane permeability. Cytometry (1993) 0.80
On the mechanism of membrane damage by Staphylococcus aureus alpha-toxin. J Cell Biol (1981) 4.06
Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores. Infect Immun (1986) 3.94
Managing drug addiction in general practice--the reality behind the guidelines: discussion paper. J R Soc Med (1987) 3.89
Randomised clinical trial comparing the effects of acupuncture and a newly designed placebo needle in rotator cuff tendinitis. Pain (1999) 3.88
Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet (2001) 3.88
The reactions of patients to a video camera in the consulting room. J R Coll Gen Pract (1984) 3.71
Mechanism of membrane damage by streptolysin-O. Infect Immun (1985) 3.26
To what extent do clinical notes by general practitioners reflect actual medical performance? A study using simulated patients. Br J Gen Pract (1994) 3.08
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron (1995) 3.08
Enzyme-linked immunoassay for detection of PCR-amplified DNA of legionellae in bronchoalveolar fluid. J Clin Microbiol (1995) 3.04
Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc Natl Acad Sci U S A (2001) 2.67
Production of listeriolysin by beta-hemolytic strains of Listeria monocytogenes. Infect Immun (1986) 2.66
Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol (2001) 2.64
Effect of school-based interventions on physical activity and fitness in children and adolescents: a review of reviews and systematic update. Br J Sports Med (2011) 2.58
Isolation and identification of two hemolytic forms of streptolysin-O. Infect Immun (1984) 2.57
Counsellors in general practice. BMJ (1988) 2.53
Direct covalent mercuration of nucleotides and polynucleotides. Biochemistry (1975) 2.50
Novel path to apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradation. Infect Immun (1994) 2.47
Training in substance abuse is lacking for GPs. BMJ (1996) 2.45
Staphylococcal alpha-toxin: oligomerization of hydrophilic monomers to form amphiphilic hexamers induced through contact with deoxycholate detergent micelles. Proc Natl Acad Sci U S A (1981) 2.38
A guide to the use of pore-forming toxins for controlled permeabilization of cell membranes. Med Microbiol Immunol (1993) 2.37
Damage to mammalian cells by proteins that form transmembrane pores. Rev Physiol Biochem Pharmacol (1987) 2.36
Multicenter evaluation of epidemiological typing of methicillin-resistant Staphylococcus aureus strains by repetitive-element PCR analysis. The European Study Group on Epidemiological Markers of the ESCMID. J Clin Microbiol (2000) 2.28
Damage to cell membranes by pore-forming bacterial cytolysins. Prog Allergy (1988) 2.23
Role of NFkappaB in the mortality of sepsis. J Clin Invest (1997) 2.18
[Non-surgical removal of a knotted Swan-Ganz catheter]. Anaesthesist (1991) 2.16
Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol (1998) 2.16
Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol (2007) 2.15
Molecular nature of the complement lesion. Proc Natl Acad Sci U S A (1978) 2.09
Testing the porphyrinogenicity of propofol in a primed rat model. Br J Anaesth (1995) 2.08
Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol (2001) 2.08
Potassium-inhibited processing of IL-1 beta in human monocytes. EMBO J (1995) 2.08
Comparison of ATB staph, rapid ATB staph, Vitek, and E-test methods for detection of oxacillin heteroresistance in staphylococci possessing mecA. J Clin Microbiol (1998) 2.05
Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation (2001) 2.02
Correlation between toxin binding and hemolytic activity in membrane damage by staphylococcal alpha-toxin. Infect Immun (1984) 2.01
Membrane damage by complement. Biochim Biophys Acta (1983) 2.00
Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology (2009) 2.00
Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch Gen Psychiatry (2001) 1.97
Complement lysis: the ultrastructure and orientation of the C5b-9 complex on target sheep erythrocyte membranes. Scand J Immunol (1978) 1.95
Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. J Clin Microbiol (1995) 1.94
Mapping of catalytic residues in the RNA polymerase active center. Science (1996) 1.91
Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol (1986) 1.83
Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence. Infect Immun (1997) 1.82
Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.78
Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection (2003) 1.77
A structural basis for four distinct elution profiles on concanavalin A--Sepharose affinity chromatography of glycopeptides. Can J Biochem (1979) 1.76
Fast quantitative diffusion-tensor imaging of cerebral white matter from the neonatal period to adolescence. Neuroradiology (2004) 1.72
Subcytocidal attack by staphylococcal alpha-toxin activates NF-kappaB and induces interleukin-8 production. Infect Immun (2001) 1.71
Acupuncture compared to placebo-acupuncture for postoperative nausea and vomiting prophylaxis: a randomised placebo-controlled patient and observer blind trial. Anaesthesia (2004) 1.71
The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development. Gut (2003) 1.70
Effect of patient-controlled analgesia on pulmonary complications after coronary artery bypass grafting. Crit Care Med (1999) 1.68
The baccalaureate isn't for everyone. Radiol Technol (1997) 1.66
Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J Exp Med (2000) 1.65
Conversion of covalently mercurated nucleic acids to tritiated and halogenated derivatives. Nucleic Acids Res (1975) 1.64
Protein sorting in Plasmodium falciparum-infected red blood cells permeabilized with the pore-forming protein streptolysin O. Biochem J (1996) 1.64
Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects. Circulation (2001) 1.64
Escherichia coli haemolysin forms voltage-dependent ion channels in lipid membranes. Biochim Biophys Acta (1987) 1.61
The Anesthesia Preoperative Evaluation Clinic (APEC): a prospective randomized controlled trial assessing impact on consultation time, direct costs, patient education and satisfaction with anesthesia care. Minerva Anestesiol (2010) 1.59
Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci U S A (1997) 1.58
Multitensor approach for analysis and tracking of complex fiber configurations. Magn Reson Med (2005) 1.58
Staphylococcal alpha-toxin-induced PGI2 production in endothelial cells: role of calcium. Am J Physiol (1985) 1.57
Mechanism of complement cytolysis and the concept of channel-forming proteins. Philos Trans R Soc Lond B Biol Sci (1984) 1.57
Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rabbits. Cardiovasc Res (1996) 1.55
Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit Care Med (1999) 1.55
Cerebral and extracerebral release of protein S100B in cardiac surgical patients. Anaesthesia (2004) 1.55
Changes in psychological diagnosis and prescription in a practice employing a counsellor. Fam Pract (1985) 1.55
Cardiac output measurement by transpulmonary versus conventional thermodilution technique in intensive care patients after coronary artery bypass grafting. J Cardiothorac Vasc Anesth (1998) 1.54
Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain. Virology (2001) 1.52
Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur J Clin Microbiol Infect Dis (2005) 1.51
Prospective longitudinal evaluation of men with initial prostate specific antigen levels of 4.0 ng./ml. or less. J Urol (1997) 1.50
Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J Clin Invest (1998) 1.50
Histidine-tagged RNA polymerase: dissection of the transcription cycle using immobilized enzyme. Gene (1993) 1.49
An activity in rat tissues that modifies nitrotyrosine-containing proteins. Proc Natl Acad Sci U S A (1998) 1.49
Inhaled nitric oxide selectively decreases pulmonary artery pressure and pulmonary vascular resistance following acute massive pulmonary microembolism in piglets. Chest (1996) 1.47
Isolation of the terminal complement complex from target sheep erythrocyte membranes. Biochim Biophys Acta (1976) 1.47
Impairments in memory and hippocampal function in HIV-positive vs HIV-negative women: a preliminary study. Neurology (2009) 1.47
Complement activation by oxidatively modified low-density lipoproteins. Eur J Clin Invest (1999) 1.47
Induction of hapten-specific tolerance by interleukin 10 in vivo. J Exp Med (1994) 1.46
Helicobacter sp. strain Mainz isolated from an AIDS patient with septic arthritis: case report and nonradioactive analysis of 16S rRNA sequence. J Clin Microbiol (1994) 1.45
Dopexamine attenuates endotoxin-induced microcirculatory changes in rat mesentery: role of beta2 adrenoceptors. Crit Care Med (1998) 1.45
Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells. Eur J Immunol (1999) 1.44
MR imaging of intracranial hemorrhage in neonates and infants at 2.35 Tesla. Neuroradiology (1991) 1.44
Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium. J Clin Invest (1984) 1.43
Quality in general practice Czech style. J R Soc Med (1987) 1.43
[Prevention of perioperative myocardial ischemia--an update]. Anaesthesist (2000) 1.42
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Crit Care Med (2001) 1.41
Antigens of the basement membrane and the peritumoral stroma in human colonic adenocarcinomas: an immunofluorescence study. Int J Cancer (1982) 1.40
Effect of dopexamine on intestinal tissue concentrations of high-energy phosphates and intestinal release of purine compounds in endotoxemic rats. Crit Care Med (2000) 1.40
Minimal requirements for exocytosis. A study using PC 12 cells permeabilized with staphylococcal alpha-toxin. J Biol Chem (1985) 1.40
Intraoperative high dose rate brachytherapy in recurrent or metastatic colorectal carcinoma. Ann Surg Oncol (1998) 1.39
Lignocaine metabolite formation: an indicator for liver dysfunction and predictor of survival in surgical intensive care patients. Anaesthesia (1995) 1.39
Detection of amphiphilic proteins and peptides in complex mixtures. Charge-shift crossed immunoelectrophoresis and two-dimensional charge-shift electrophoresis. Biochim Biophys Acta (1977) 1.38
Mental number line training in children with developmental dyscalculia. Neuroimage (2011) 1.38
Mitempfindung. Do you get it? Ir Med J (1991) 1.38
Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin. Infect Immun (1991) 1.37
Ultrasound control for presumed difficult epidural puncture. Acta Anaesthesiol Scand (2001) 1.36
The terminal membrane C5b-9 complex of human complement. Evidence for the existence of multiple protease-resistant polypeptides that form the trans-membrane complement channel. J Immunol (1980) 1.36
Staphylococcal alpha-toxin-induced vascular leakage in isolated perfused rabbit lungs. Lab Invest (1990) 1.35